The potential of innovative cancer therapies, especially chimeric antigen receptor T-cell (CAR-T) therapies, is being explored for treating patients with autoimmune diseases. Marco Ruella, MD, will provide an overview of CAR-T production and therapeutic use.

Studies have shown that the main reason why people from historically marginalized communities haven’t participated in clinical trials is that no one asked them, said one of the featured speakers, Janet Pope, MD, FRCPC, MPH.

Questions can be more effective for learners than reading or taking notes, in part because the act of retrieval makes that information more readily available in the future, as Jonathan Hausmann, MD, will explain in this session.